Bingfang Yan

7.0k total citations · 1 hit paper
109 papers, 5.7k citations indexed

About

Bingfang Yan is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Bingfang Yan has authored 109 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 37 papers in Oncology and 33 papers in Pharmacology. Recurrent topics in Bingfang Yan's work include Pharmacogenetics and Drug Metabolism (29 papers), Drug Transport and Resistance Mechanisms (28 papers) and Cholinesterase and Neurodegenerative Diseases (16 papers). Bingfang Yan is often cited by papers focused on Pharmacogenetics and Drug Metabolism (29 papers), Drug Transport and Resistance Mechanisms (28 papers) and Cholinesterase and Neurodegenerative Diseases (16 papers). Bingfang Yan collaborates with scholars based in United States, China and Japan. Bingfang Yan's co-authors include Dongfang Yang, Deshi Shi, Liangran Guo, Wei Lü, Edward L. LeCluyse, Xiulong Song, Ruitang Deng, Jian Yang, Yajuan Li and Mingxing Xie and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Bingfang Yan

108 papers receiving 5.6k citations

Hit Papers

Combinatorial Photothermal and Immuno Cancer Therapy Usin... 2014 2026 2018 2022 2014 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Combinatorial Photothermal and Immuno Cancer Therapy Using Chitosan-Coated Hollow Copper Sulfide Nanoparticles
    2014 474 citations Bingfang Yan et al. profile →

Peers

Bingfang Yan
Xi Zheng China
Dongming Xing China
Jianwen Liu China
Yong‐Yeon Cho South Korea
Miguel López‐Lázaro Spain
Dongwei Zhang China
Edith Sim United Kingdom
Jacques Magdalou France
Frank Arfuso Australia
Na Lu China
Xi Zheng China
Bingfang Yan
Citations per year, relative to Bingfang Yan Bingfang Yan (= 1×) peers Xi Zheng

Countries citing papers authored by Bingfang Yan

Since Specialization
Citations

This map shows the geographic impact of Bingfang Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingfang Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingfang Yan more than expected).

Fields of papers citing papers by Bingfang Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bingfang Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingfang Yan. The network helps show where Bingfang Yan may publish in the future.

Co-authorship network of co-authors of Bingfang Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Bingfang Yan. A scholar is included among the top collaborators of Bingfang Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bingfang Yan. Bingfang Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yan, Bingfang, et al.. (2023). Oral Drug Delivery via Intestinal Lymphatic Transport Utilizing Lipid-Based Lyotropic Liquid Crystals. SHILAP Revista de lepidopterología. 3(4). 456–468. 11 indexed citations
2.
Wu, Yi‐Chen, Haobin Wang, Ying Huo, et al.. (2023). Differentiated embryonic chondrocyte expressed gene-1 is a central signaling component in the development of collagen-induced rheumatoid arthritis. Journal of Biological Chemistry. 299(3). 102982–102982. 3 indexed citations
3.
4.
Zhou, Qiongqiong, Bingfang Yan, Wanying Sun, et al.. (2021). Pig Liver Esterases Hydrolyze Endocannabinoids and Promote Inflammatory Response. Frontiers in Immunology. 12. 670427–670427. 8 indexed citations
5.
Zhang, Yuan, et al.. (2018). Gemcitabine nanoparticles promote antitumor immunity against melanoma. Biomaterials. 189. 48–59. 96 indexed citations
6.
Wu, Lili, Hafiz Muhammad Zubair, Jing Xiong, et al.. (2017). 17β-estradiol suppresses carboxylesterases by activating c-Jun/AP-1 pathway in primary human and mouse hepatocytes. European Journal of Pharmacology. 819. 98–107. 18 indexed citations
7.
Chen, Yi-Tzai, Lynnie Trzoss, Dongfang Yang, & Bingfang Yan. (2015). Ontogenic expression of human carboxylesterase-2 and cytochrome P450 3A4 in liver and duodenum: Postnatal surge and organ-dependent regulation. Toxicology. 330. 55–61. 33 indexed citations
8.
Liu, Jiayong, Juan Yao, Li Xm, et al.. (2014). Pathogenic role of lncRNA-MALAT1 in endothelial cell dysfunction in diabetes mellitus. Cell Death and Disease. 5(10). e1506–e1506. 367 indexed citations
9.
Shi, Deshi, Dongfang Yang, Eric Prinssen, Brian E. Davies, & Bingfang Yan. (2011). Surge in Expression of Carboxylesterase 1 During the Post-neonatal Stage Enables a Rapid Gain of the Capacity to Activate the Anti-influenza Prodrug Oseltamivir. The Journal of Infectious Diseases. 203(7). 937–942. 50 indexed citations
10.
Yang, Jian, Dongfang Yang, Deshi Shi, et al.. (2010). Pregnane X receptor is required for interleukin-6-mediated down-regulation of cytochrome P450 3A4 in human hepatocytes. Toxicology Letters. 197(3). 219–226. 57 indexed citations
11.
Li, Yuxin, Qiang Shen, Hee-Tae Kim, et al.. (2010). The rexinoid bexarotene represses cyclin D1 transcription by inducing the DEC2 transcriptional repressor. Breast Cancer Research and Treatment. 128(3). 667–677. 35 indexed citations
12.
Shi, Deshi, Dongfang Yang, & Bingfang Yan. (2010). Dexamethasone transcriptionally increases the expression of the pregnane X receptor and synergistically enhances pyrethroid esfenvalerate in the induction of cytochrome P450 3A23. Biochemical Pharmacology. 80(8). 1274–1283. 35 indexed citations
13.
Kaimal, Rajani, Xiulong Song, Bingfang Yan, Robert J. King, & Ruitang Deng. (2009). Differential Modulation of Farnesoid X Receptor Signaling Pathway by the Thiazolidinediones. Journal of Pharmacology and Experimental Therapeutics. 330(1). 125–134. 33 indexed citations
14.
Deng, Ruitang, Dongfang Yang, Jian Yang, & Bingfang Yan. (2006). Oxysterol 22(R)-Hydroxycholesterol Induces the Expression of the Bile Salt Export Pump through Nuclear Receptor Farsenoid X Receptor but Not Liver X Receptor. Journal of Pharmacology and Experimental Therapeutics. 317(1). 317–325. 50 indexed citations
15.
Song, Xiulong, et al.. (2005). Simultaneous Substitution of Phenylalanine-305 and Aspartate-318 of Rat Pregnane X Receptor with the Corresponding Human Residues Abolishes the Ability to Transactivate the CYP3A23 Promoter. Journal of Pharmacology and Experimental Therapeutics. 312(2). 571–582. 18 indexed citations
16.
Liu, Jirong, Xiulong Song, Yuxin Li, et al.. (2005). Clofibrate and perfluorodecanoate both upregulate the expression of the pregnane X receptor but oppositely affect its ligand-dependent induction on cytochrome P450 3A23. Biochemical Pharmacology. 69(9). 1363–1371. 11 indexed citations
17.
Nam, Nguyen‐Hai, Rebecca Pitts, Gongqin Sun, et al.. (2004). Design of tetrapeptide ligands as inhibitors of the Src SH2 domain. Bioorganic & Medicinal Chemistry. 12(4). 779–787. 27 indexed citations
18.
19.
20.
Rafaeloff, Ronit, Gary L. Pittenger, F. Xiao‐Feng Qin, et al.. (1997). Cloning and sequencing of the pancreatic islet neogenesis associated protein (INGAP) gene and its expression in islet neogenesis in hamsters.. Journal of Clinical Investigation. 99(9). 2100–2109. 187 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xi Zheng Breakdown of academic impact, for papers by Dongming Xing Breakdown of academic impact, for papers by Jianwen Liu Breakdown of academic impact, for papers by Yong‐Yeon Cho Breakdown of academic impact, for papers by Miguel López‐Lázaro Breakdown of academic impact, for papers by Dongwei Zhang Breakdown of academic impact, for papers by Edith Sim Breakdown of academic impact, for papers by Jacques Magdalou Breakdown of academic impact, for papers by Frank Arfuso Breakdown of academic impact, for papers by Na Lu
Rankless by CCL
2026